Apr 13, 2023, 10:29 AM by

Phastar Supports Great Ormond Street Rare Disease Study Through Pro Bono Scheme Biometrics experts support trial of new treatment for children with severe combined immunodeficiency

Apr 13, 2023, 10:26 AM by

Blue Spark Technologies, Inc., a leader in wearable remote patient monitoring solutions, will showcase TempTraq® at the HIMSS Global Health Conference & Exhibition at McCormick Place Convention Center in Chicago April 17-21.

Apr 13, 2023, 10:02 AM by

CD BioSciences has recently launched comprehensive research solutions for studying cell death, particularly the apoptotic cell death.

Apr 13, 2023, 10:01 AM by

STEMart has recently introduced the Bioburden and Sterility Testing services for medical devices.

Apr 13, 2023, 10:00 AM by

Creative Diagnostics recently introduced the Microneutralization Assay Service to support research labs in detecting virus-specific neutralizing antibodies from human and animal sera.

Apr 13, 2023, 09:58 AM by

Apr 13, 2023, 09:55 AM by

Endor Labs, the startup helping development and security teams maximize the use of open source software (OSS), today launched in private beta Endor Labs DroidGPT – an AI that can help developers select better open source software.

Apr 13, 2023, 01:00 AM by User Not Found

Bio-IT World | Researchers at the University of Utah have created a systematic approach to reveal the endogenous protein-metabolite interactome at high-throughput speed. The platform quickly identifies metabolites that putatively interact with target proteins.

Apr 11, 2023, 01:01 AM by User Not Found

Bio-IT World | Retinal scans offer a fascinating window into the health of the body’s circulatory system and brain functioning as well as identify eye diseases that aren't visibly noticeable. Now, a new study suggests that this artificial intelligence-based technology is also good for predicting how well people are aging.

Apr 7, 2023, 11:46 AM by

In the wake of the COVID-19 pandemic, BOC Sciences, the world's reputed chemical supplier, declares that it will increase production to offer pharmaceutical impurity standards in bulk to satisfy unmet demands.

Apr 7, 2023, 11:44 AM by

Apr 7, 2023, 11:42 AM by

Apr 7, 2023, 11:41 AM by

Alfa Chemistry, known as a chemical supplier for various high-quality chemicals and materials for both academia and the industry, has recently extended its offering scope to vaccine related products, including but not limited to: vaccine excipients, nucleic acid delivery excipients, cell culture media and pharmaceutical packaging.

Apr 7, 2023, 11:41 AM by

Apr 7, 2023, 11:35 AM by

Apr 7, 2023, 11:35 AM by

Bio-Rad is accelerating measurable residual disease (MRD) research through more than a half dozen collaborations with institutions and companies leveraging its new QX600™ Droplet Digital™ PCR System, which boasts six color detection capable of quantifying 12 targets per well, a simple user workflow, and powerful data analysis. Maintaining Bio-Rad’s best-in-class ddPCR™ technology, this platform utilizes the same droplet generation and processing protocols as the QX200™ system, enabling thousands of current customers to adopt its advanced multiplexing capabilities easily.

Apr 7, 2023, 11:34 AM by

VERICHEM LABORATORIES now offers clinical laboratorians an extensive range of multi-level liquid stable biosynthetic clinical reference materials intended for use with urine chemistry assays.

Apr 7, 2023, 01:00 AM by User Not Found

Bio-IT World | When implementing laboratory automation, one of the biggest challenges can be group dynamics: getting scientific and IT teams on the same page. Both groups are integral to the success of an automated setup, but often they have very different perspectives and might even be resistant to working together. It’s important to understand why so that we can overcome this issue.

Apr 6, 2023, 10:34 AM by

IRT represents a QSP platform of immune system, simultaneously, being a tool for development of models related to immune system. IRT update focuses on usability and efficiency of search for information on the platform.

Apr 6, 2023, 10:32 AM by